Prognostic Implications of Widespread FDG Uptake in Spleen and/or Bone Marrow Linked to Reticuloendothelial System Activation in Patients with Lymphoma - Top-Institutions - MDSpire

Prognostic Implications of Widespread FDG Uptake in Spleen and/or Bone Marrow Linked to Reticuloendothelial System Activation in Patients with Lymphoma

By
Yuru Song
Jiaqi Sun
Jing Jiang
Ningjun Xu
Qian Zhao
January 17, 2026
0 min

Bmc Cancer

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

#1

Memorial Sloan Kettering Cancer Center

New York, NY
Key Differentiators
- Hematology-Oncology
- Nuclear Medicine
- Molecular Imaging
#2

MD Anderson Cancer Center

Houston, TX
Key Differentiators
- Hematology-Oncology
- Nuclear Medicine
- Immunology
#3

Dana-Farber Cancer Institute

Boston, MA
Key Differentiators
- Hematology-Oncology
- Nuclear Medicine
- Translational Research
#4

Johns Hopkins Hospital

Baltimore, MD
Key Differentiators
- Hematology-Oncology
- Nuclear Medicine
- Immunopathology
#5

University of Pennsylvania (Perelman School of Medicine)

Philadelphia, PA
Key Differentiators
- Hematology-Oncology
- Nuclear Medicine
- Cancer Immunology

Original Source(s)

Bmc Cancer

Prognostic Implications of Widespread FDG Uptake in Spleen and/or Bone Marrow Linked to Reticuloendothelial System Activation in Patients with Lymphoma

by Yuru Song, Jiaqi Sun, Jing Jiang, Ningjun Xu, Qian Zhao
January 17, 2026

Related Content

Bmc Cancer

Evaluating the Diagnostic Utility of High-Frame-Rate Contrast-Enhanced Ultrasound and a Nomogram for Lymphoma Assessment

by Yu Song, Yahan Zhang, Linlin Zhang, Ying Che, Manxi Li
November 19, 2025

Frontiers In Hematology

Mechanisms of kinase inhibitor resistance in subtypes of cutaneous T-cell lymphomas

Dana-Farber

Dana-Farber Research Helps Drive FDA Label Update for Primary CNS Lymphoma

Change removes prior exclusion and may expand access to CAR T-cell therapy for eligible relapsed or refractory patients

by
February 9, 2026
3 min